Tip 89b: probiotics 3

A large RCT using a single probiotic, Bifidobacterium breve, in 23-30 week gestation babies, showed no difference in the outcomes of NEC, sepsis or death before discharge.

Reference: Costeloe, K., Hardy, P., Juszczak, E., Wilks, M. and Millar, M.R., 2016. Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial. The Lancet; 387 (10019): 649-660. (1315 infants).

This entry was posted in Gastrointestinal, Infection, Trials. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.